Goldman Sachs Downgrades Xylem (XYL) to Sell

Goldman Sachs analyst Brian Lee downgraded Xylem (NYSE: XYL) from Neutral to Sell with a price target of $56.00 (from $77.00).

For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.

Shares of Xylem closed at $66.19 yesterday.

You May Also Be Interested In

• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
• Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
• Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral